Biopharmaceutical Manufacturing Trends 2013 Excellence Within a Rapidly Changing LandscapeFocus on EfficiencyThe biopharma industry’s continued focus on process efficiency is being fueled by advances in biosimilars, smaller volume drugs, shorter drug lifecycles (faster trials, development cycles), and high-volume product manufacturing issues. To evaluate the trends that are shaping the bioprocessing segment today, BioPlan Associates recently surveyed 450 global subject matter experts and senior participants on its Biotechnology Industry Council panel of bioprocessing professionals and asked them to identify the most critical factors and trends they expect will need to be addressed over the coming year. While 'process efficiency' was a unifying thread, three clear sub-topics emerged: downstream processing; analytical methods development; and single-use system integration. (1) This year, the industry will see an increase in multi-product facilities, selective single-use adoption (both in clinical and commercial stage), a ramping up of continuous processing, and more advanced automation and monitoring. With downstream processing continuing to lag improvements upstream, the industry will continue to look for better performing chromatography resins and consider alternatives to protein A.
Read more about: Downstream Processing, Analytical Methods, Single-Use Systems Integration and more when you download the complete eBook.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment